Navigating the labyrinth of CSU management

Unable to attend EAACI Congress 2024?

What are the challenges in diagnosis for people with chronic spontaneous urticaria (CSU)? Where are the hurdles throughout the patient journey? And how can emerging treatments help improve outcomes for people with CSU?

Professor Ana Maria Giménez-Arnau (Spain), Professor Simon Francis Thomsen (Denmark) and Professor Martin Metz (Germany) will discuss these key topics during a Novartis-sponsored symposium at the European Academy of Allergy & Clinical Immunology (EAACI) Congress 2024.

Register to access the symposium recording.

Agenda

Don’t miss this opportunity to gain expert perspective on this complex and evolving topic

Faculty

Professor Ana Maria Giménez-Arnau

Ana Maria Giménez-Arnau is Associate Professor of Dermatology at Pompeu Fabra University, Barcelona, Spain. She is also a consultant physician in dermatology and venereology at the Hospital del Mar, Barcelona, Spain. Her main scientific areas of interest are urticaria, eczema, contact dermatitis and atopic dermatitis.

Disclosures: Honoraria as a speaker and/or consultant: Almirall, Amgen, AstraZeneca, Avène, Celldex, Escient Pharmaceuticals, Genentech, GSK, Instituto Carlos III-FEDER, Leo Pharma, Menarini, Mitsubishi Tanabe Pharma, NOUCOR, Novartis, Sanofi‑Regeneron, Servier, Thermo Fisher Scientific, and Uriach.

Professor Martin Metz

Martin Metz is Professor of Dermatology at the Institute of Allergology at Charité–Universitätsmedizin Berlin, Germany, and at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology. His main scientific areas of interest are mast cell biology, neuroimmunology, inflammation and innate immunity. He has a major clinical and translational focus on pruritus and mast cell-mediated diseases.

Disclosures: Honoraria as a speaker and/or consultant: AbbVie, Almirall, Amgen, argenx, AstraZeneca, Bayer, Beiersdorf, Celldex Therapeutics, Celltrion, Escient Pharmaceuticals, Galderma, GSK, Jasper Therapeutics, Novartis, Pfizer, Pharvaris, Sanofi, Teva Pharmaceuticals, Third Harmonic Bio, and Vifor Pharma.

Professor Simon Francis Thomsen

Simon Francis Thomsen is a dermatologist and professor at the Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark. His research focuses on the aetiology, clinical course and treatment of chronic inflammatory skin diseases, particularly chronic urticaria.

Disclosures: Research support: Janssen, LEO Pharma, Novartis, Sanofi, and UCB. Speaker/consultant: AbbVie, Almirall, Eli Lilly, Galderma, Incyte, Janssen, LEO Pharma, Novartis, Pfizer, Sanofi, Symphogen, UCB, and Union Therapeutics.